Full‑Scenario Clinical Applications: Ultrasound‑Visible Needles Empowering Precision Diagnosis And Treatment Across Departments

May 11, 2026

Leveraging core strengths of visualized puncture, minimally invasive safety, and broad compatibility, ultrasound‑visible needles are widely adopted in diverse interventional procedures across clinical departments, covering both diagnostic and therapeutic workflows. As indispensable consumables for modern precision and minimally invasive medicine, they deliver robust support for early diagnosis and targeted treatment of various diseases.

 

In pathological biopsy procedures, ultrasound‑visible needles serve as primary instruments for retrieving lesional tissue samples. For nodules and space‑occupying lesions in the thyroid, breast, liver, kidney, lymph nodes, and other organs, real‑time ultrasound guidance enables clinicians to clearly visualize the needle's puncture trajectory and precisely advance the tip into the lesion core for rapid tissue sampling, laying a reliable foundation for pathological diagnosis. Compared with conventional biopsy techniques, ultrasound‑visible needles enable accurate targeting with minimal trauma, effectively avoiding adjacent blood vessels and nerves to reduce bleeding and tissue injury. They also improve sample adequacy, minimize repeated punctures, and facilitate precise differentiation between early malignant and benign lesions, enabling early detection and intervention.

 

In pain management and anesthetic nerve blocks, ultrasound‑visible needles enable targeted drug delivery and efficient analgesia. Indications include cervical, shoulder, lumbar, and leg pain, post‑herpetic neuralgia, postoperative pain, as well as brachial plexus and sciatic nerve blocks for surgical anesthesia. The needle's high echogenicity allows accurate perineural drug injection to achieve precise nerve blockade and localized analgesia or anesthesia, eliminating risks of uneven drug dispersion and nerve injury. In contrast to blind nerve block techniques, ultrasound‑guided procedures with visible needles yield more reliable pain relief, faster anesthetic onset, and extremely low complication rates, enhancing the safety and efficacy of pain therapy and surgical anesthesia.

 

For effusion/cyst aspiration and drainage, ultrasound‑visible needles offer a minimally invasive solution for intralesional fluid management. In cases of pleural effusion, ascites, pericardial effusion, hepatic cysts, renal cysts, and thyroid cysts, ultrasound‑guided puncture allows safe aspiration, sclerotherapy, or catheter drainage without open surgery. The approach minimizes trauma, accelerates recovery, and rapidly relieves compressive symptoms while lowering risks of infection and hemorrhage, making it particularly suitable for frail patients or those unfit for surgical intervention.

 

In vascular access and interventional therapy, ultrasound‑visible needles significantly improve cannulation success rates. For peripheral venipuncture, central venous catheterization, and arterial puncture-especially in difficult‑access populations such as obese patients, pediatric patients, and those with poor venous conditions-ultrasound visualization clearly displays vessel location, course, and depth. This enables rapid, precise vascular access, reduces patient discomfort from repeated attempts, and lowers complications such as vessel perforation and hematoma formation, laying a foundation for subsequent infusion, transfusion, hemodialysis, and interventional drug delivery.

 

Additionally, ultrasound‑visible needles are extensively used in minimally invasive procedures including percutaneous fistulization, intratumoral drug injection, and seed implantation, covering departments such as radiology, interventional medicine, general surgery, nephrology, and gynecology. Their multi‑department, all‑scenario utility highlights strong clinical practicality. With the growing adoption of minimally invasive interventional techniques, the clinical scope of ultrasound‑visible needles will continue to expand, positioning them as core consumables driving the advancement of clinical diagnosis and treatment models.

news-1-1